- CRS Publications
- News
News
Authors:
Date:
Business Wire: September 14, 2017 – CAMBRIDGE, MA, U.S.A. – Seqirus announced today that the U.S. Food and Drug Administration (FDA) has approved Afluria Quadrivalent (influenza vaccine) for use in people five years of age and older, extending the company’s broad portfolio of influenza vaccine…
Authors:
Date:
BOCA RATON, FL, U.S.A. – TherapeuticsMD, Inc. (NYSE American: TXMD), an innovative women’s healthcare company, today announced the submission of the additional endometrial safety information that was requested by the Food and Drug Administration (FDA) in its recent General Advice Letter to the…
Date:
Business Wire: September 14, 2017 – BOSTON, MA, U.S.A., and PFÄFFIKON, Switzerland – Intarcia Therapeutics, Inc., and Numab Therapeutics AG today announced the achievement of a key milestone in their ongoing development partnership—the selection of a multispecific antibody construct targeting…
Authors:
Date:
Business Wire: September 13, 2017 – LOS ANGELES, CA, U.S.A. – Biosciences, Inc., a bio-targeted nanomedicines company developing a novel nanoparticle drug delivery platform, with a proprietary oncology pipeline, announced that the U.S. Patent and Trademark Office has issued U.S. patent no. 9,757,…
Authors:
Date:
Business Wire: September 12, 2017 – FORT WORTH, TX, U.S.A. – DFB Pharmaceuticals, a private investment and development group, in collaboration with CritiTech and US Biotest, has formed NanOlogy to finance and develop a breakthrough technology platform to produce unique, patented, naked nanoparticle…
Authors:
Date:
PRNewswire: September 12, 2017 – BARCELONA, Spain – Lipofoods, SLU, launches Newcaff™ microcapsules, a natural, slowrelease caffeine formulation for athletes and others living an active lifestyle. The company will introduce Newcaff microcapsules at SupplySide West, Las Vegas, September 28–29, 2017…
